249 related articles for article (PubMed ID: 12600649)
1. Epidemiology of hepatitis C virus infection in Australia.
Dore GJ; Law M; MacDonald M; Kaldor JM
J Clin Virol; 2003 Feb; 26(2):171-84. PubMed ID: 12600649
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.
Gidding HF; Topp L; Middleton M; Robinson K; Hellard M; McCaughan G; Maher L; Kaldor JM; Dore GJ; Law MG
J Gastroenterol Hepatol; 2009 Oct; 24(10):1648-54. PubMed ID: 19798783
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of hepatitis C virus infection among injecting drug users in Australia.
Crofts N; Jolley D; Kaldor J; van Beek I; Wodak A
J Epidemiol Community Health; 1997 Dec; 51(6):692-7. PubMed ID: 9519134
[TBL] [Abstract][Full Text] [Related]
4. Modelling the hepatitis C virus epidemic in Australia.
Razali K; Thein HH; Bell J; Cooper-Stanbury M; Dolan K; Dore G; George J; Kaldor J; Karvelas M; Li J; Maher L; McGregor S; Hellard M; Poeder F; Quaine J; Stewart K; Tyrrell H; Weltman M; Westcott O; Wodak A; Law M
Drug Alcohol Depend; 2007 Dec; 91(2-3):228-35. PubMed ID: 17669601
[TBL] [Abstract][Full Text] [Related]
5. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
6. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
[TBL] [Abstract][Full Text] [Related]
7. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
8. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
Falster K; Kaldor JM; Maher L;
J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
[TBL] [Abstract][Full Text] [Related]
10. Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group.
Law MG
J Gastroenterol Hepatol; 1999 Nov; 14(11):1100-7. PubMed ID: 10574138
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of hepatitis C virus infection in Pakistan.
Raja NS; Janjua KA
J Microbiol Immunol Infect; 2008 Feb; 41(1):4-8. PubMed ID: 18327420
[TBL] [Abstract][Full Text] [Related]
13. Childhood hepatitis C virus infection: An Australian national surveillance study of incident cases over five years.
Raynes-Greenow C; Polis S; Elliott E; Hardikar W; Kesson A; Kaldor J; Jones CA
J Paediatr Child Health; 2015 Nov; 51(11):1115-20. PubMed ID: 25940977
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges.
Hutchinson SJ; Roy KM; Wadd S; Bird SM; Taylor A; Anderson E; Shaw L; Codere G; Goldberg DJ
Scott Med J; 2006 May; 51(2):8-15. PubMed ID: 16722130
[TBL] [Abstract][Full Text] [Related]
15. Surveillance for newly acquired hepatitis C in Australia.
Robotin MC; Copland J; Tallis G; Coleman D; Giele C; Carter L; Spencer J; Kaldor JM; Dore GJ
J Gastroenterol Hepatol; 2004 Mar; 19(3):283-8. PubMed ID: 14748875
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of hepatitis C in the United States.
Williams I
Am J Med; 1999 Dec; 107(6B):2S-9S. PubMed ID: 10653448
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
Xia X; Luo J; Bai J; Yu R
Public Health; 2008 Oct; 122(10):990-1003. PubMed ID: 18486955
[TBL] [Abstract][Full Text] [Related]
18. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
[TBL] [Abstract][Full Text] [Related]
19. Beyond injecting drug use: investigation of a Victorian cluster of hepatitis C among HIV-infected men who have sex with men.
Mahony AA; Donnan EJ; Lester RA; Doyle JS; Knox J; Tracy SL; Bowden S; Sasadeusz JJ
Med J Aust; 2013 Mar; 198(4):210-4. PubMed ID: 23451966
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C prevalence--a nationwide serosurvey.
Amin J; Gidding H; Gilbert G; Backhouse J; Kaldor J; Dore G; Burgess M
Commun Dis Intell Q Rep; 2004; 28(4):517-21. PubMed ID: 15745402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
